Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Solid Biosciences

Solid Biosciences?uq=2zON1W4M
2013 FOUNDED
PUBLIC STATUS
51-60 EMPLOYEES
SLDB STOCK SYMBOL
2 INVESTMENTS
$51.70 SHARE PRICE (As of Thursday Closing)
Description

Developer of gene therapies designed to treat patients with Duchenne Muscular Dystrophy (DMD). The company's gene therapies focus on providing novel, disease modifying and assistive devices, targeting the many facets of the disease, enabling patients to get cured from the underlying genetic cause.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 161 First Street
  • Third Floor
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solid Biosciences’s full profile, request a free trial.

Solid Biosciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$7.19 - $51.70 $1.74B $49.06 207K 35.4M

Solid Biosciences Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 1,100,751
Revenue 0 0 0 0
EBITDA (61,226) (52,949) (24,086) (6,667)
Net Income (61,849) (52,118) (21,539) (6,377)
Total Assets 171,470 76,193 40,636 55,696
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Solid Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Solid Biosciences‘s full profile, request access.

Request full access to PitchBook

Solid Biosciences Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00 30-Mar-2017 000000000000000000 Biotechnology 0000 00000
Solid GT Angel (individual) 0000 Biotechnology 0000 00000
To view this company’s complete investment and acquisition history, request access »

Solid Biosciences Subsidiaries (1)

Company Name Industry Location Founded
00000 00 Biotechnology Cambridge, MA 0000
To view this company’s complete subsidiary history, request access »

Solid Biosciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Solid Biosciences‘s full profile, request access.

Request full access to PitchBook

Solid Biosciences Executive Team (10)

Name Title Board
Seat
Contact
Info
Ilan Ganot Co-Founder, President, Chief Executive Officer & Board Member
Jennifer Ziolkowski Chief Financial Officer
Alvaro Amorrortu Chief Operating Officer
Joel Schneider Ph.D Chief Technology Officer & Head of Exploratory Research & Development
Carl Morris Ph.D Chief Scientific Officer

1 Former Executive

You’re viewing 5 of 10 executives. Get the full list »

Solid Biosciences Board Members (9)

Name Representing Role Since Contact
Info
Adam Koppel Ph.D Bain Capital Board Member 000 0000
Adam Stone Perceptive Advisors Board Member 000 0000
Andrey Zarur Ph.D Self Co-Founder & Chairman 000 0000
Ilan Ganot Solid Biosciences Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Lynne Sullivan Solid Biosciences Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »